Group items tagged

Head & neck cancers include a number of different malignant tumors that develop in or around the throat, larynx, nose, sinuses, lips, salivary glands, and mouth. There are different types of drugs used alone or in combination for treatment of head & neck cancer. Although traditional chemotherapeutic drugs preferably used in combination of radiation therapy, targeted immune therapies are emerging as a standard treatment option for advanced-stage head & neck cancers.

The drug controller issued emergency use authorization to pharmaceutical businesses in India to produce generic versions of molnupiravir.

Nucleic Acid Testing reort presents strategic assessments of current and emerging suppliers of nucleic acid testing products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

Overview: The webinar will concentrate on topics that HHS has announced will be the focus of the first round of "desk audits". They reflect significant areas of non-compliance revealed in the 2012 pilot audits and HHS HIPAA violation investigations concluded by Resolution Agreements and Corrective Action Plans. They include: HIPAA Risk Analysis Risk Management based on Risk Analysis Breach Notification Notice of Privacy Practices (for Covered Entities) Minimum Necessary Standard Access of Individuals to their PHI Authorizations Workforce Training This webinar is vital because, in focusing on preparation for a HIPAA Compliance Audit, Covered Entities and Business Associates may review, prioritize and structure their HIPAA Compliance programs. If you have HIPAA Compliance documentation ready to submit on two weeks notice to HHS you are implementing an effective HIPAA Compliance program. In addition, every Covered Entity or Business Associate may face an HHS HIPAA Compliance investigation at any time due to a complaint or a Breach. If you are "audit ready" you will be ready for an investigation - and better able to avoid complaints and prevent breaches. Why should you attend: Every Covered Entity and Business Associate is liable - without prior notice - to be audited for HIPAA Compliance by HHS You will have only 2 weeks after receiving your HIPAA Compliance Audit notification and data request to upload all requested documents to an HHS HIPAA Compliance Audit Portal The HIPAA Compliance Audit data request you receive will specify content and file organization, file names and any other document submission requirements Auditors will not contact an audited entity for clarifications or ask for additional information - it is essential that submitted documents are current, accurately reflect the entity's HIPAA Compliance program and demonstrate HIPAA Compliance Only data submitted on time will be assessed Failure to respond on time may be referred to the HHS regional

Women Personal Safety in Delhi, NCR is the biggest issue for every citizen. Keep your loved ones safe with the women security device of OTER.

Coronavirus is still very much around, and with the threatening death toll, the famous movie star Jackie Chan has promised 1 million yuan for anyone who finds a cure for this deadly virus. What a remarkable step by him.

CMS has always proven to be an authority that speaks in favor of clinicians and address their concerns. Due to the unfortunate situation of coronavirus outbreak, doctors and other clinicians were facing quite some issues regarding submitting data to CMS.

Dr P.P. Singh has emerged as the best Urology Surgeon in Delhi catering the best treatment at the modest prices. He holds great knowledge in this field. Go through the official site to accumulate more information.

We are dealing with a public health emergency, and CMS has proactively come forward to facilitate clinicians in Quality Payment Program (QPP). This year, the final rule for QPP MIPS data submission required some flexibility to accommodate the pressure.

The term "portable diagnostic device" (or PDD for short) refers to a wide range of medical devices that are either made for external use (that can be used in the field) or for internal use in the doctor's office. They are designed to be used quickly and easily by any patient and also provides continuous and non-invasive monitoring of health parameters. Moreover, they also provide real-time information to a healthcare provider through connectivity. Growing advancement in the field of medical device such as smart wearable's and image-guided therapy systems is predominantly fueling the growth of the portable diagnostic device market. For instance, in January 2019, Royal Philips announced Azurion with FlexArm, to set a new standard for patient imaging and positioning flexibility for image-guided procedures. Rising awareness regarding the advantage of portable medical devices is again anticipated to foster market growth. Increasing the manufacturer's focus on the development of compact, wireless, and user-friendly is again projected to foster the growth of the portable diagnostic device market. Growing advancement in the field of embedded systems, sensors, and electronics is contributing to market growth over the forecast period. Also, the growing geriatric population is increasing the prevalence of chronic diseases such as diabetes and cancer which is again driving demand for portable diagnostic devices. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/are-smart-wearable-and-image-guided.html

Advanced Enzymes has emerged as a dominant player in the highly specialized enzyme market. We are engaged in the research and development, manufacturing and marketing of over 400 proprietary products developed from over 65 indigenous enzymes & Probiotics.

When private practices follow Trump Administration's Guidelines for Opening Up America, medical billing services, as their business associates, support them in a spirited way. From accounts receivable management to payment posting, medical billing services such as P3Care look to expedite the process for increased stability.

COVID emergency relief funds restrict medical billing services from sending surprise bills to patients on behalf of clinicians. Does this mean surprise billing is about to end?

COVID-19 has taken over the world. The coronavirus emergency has become so big that the regular medical procedures have taken a back seat until the situation gets any better. CMS - The Centers for Medicare and Medicaid has announced that all the nonessential surgical, diagnostic, and dental procedures should be delayed during the novel corona outbreak.